Events & News


The Use of Virtual Controls in Preclinical Research: Promise and Predicament

Join BioCelerate for its second meeting of the BioCelerate Preclinical Collaboration Forum, which brings together cross-industry stakeholders to advance conversation and innovation in preclinical research.

Leveraging CDISC SEND Data Sets for Study Analyses


Janice Chang Named New CEO of TransCelerate and BioCelerate

BioCelerate Newsletter – November 2021

Harmonization of SEND Implementation to Enable Historical Control Data Analysis, the Recommendations for Populating Control Type (TCNTRL) with CDISC SEND Controlled Terminology White Paper was published on the PHUSE website

BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA

BioCelerate Newsletter – April 2021

SEND Implementation for Cross-Study Analysis Initiative Publishes New Manuscript: Leveraging the Value of CDISC SEND Datasets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals

BioCelerate Newsletter – November 2020

BioCelerate Newsletter – March 2020

BioCelerate Featured in Applied Clinical Trials

BioCelerate Releases V1.1 of the Nonclinical Protocol Template for Repeat-Dose Toxicology Studies

BioCelerate Newsletter – November 2019

BioCelerate Launches Two New Initiatives and Expands Membership

BioCelerate Newsletter – April 2019

TransCelerate and BioCelerate Launch New Technology Platform to Enable R&D Data Sharing

TransCelerate BioPharma Introduces New Subsidiary BioCelerate to Increase Efficiencies in Preclinical Research